PASSAGE BIO, INC. Peo Total Comp Amt
PASSAGE BIO, INC. (PASG) reported Peo Total Comp Amt of $1.49 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-07.
Financial Statements › Notes
ecd:PeoTotalCompAmt · last filed 2026-04-07
| Period end | Peo Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $1.49M DEF 14A · filed 2026-04-07 |
| 2024-12-31 | $1.64M DEF 14A · filed 2026-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |